| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 30 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 65,000 | $0.17 | $11,300.00 | +0.2% | |
| Oct 18, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 45,000 | $0.19 | $8,700.00 | +0.2% | |
| Oct 14, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 97,500 | $0.18 | $17,200.00 | +0.4% | |
| Oct 12, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 165,000 | $0.08 | $13,250.00 | +0.7% | |
| Oct 11, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 185,000 | $0.11 | $20,370.00 | +0.2% | |
| Jul 19, 2022 | Lee Willis C | COO | Buy | 3,200 | $0.39 | $1,248.00 | +1.1% | |
| May 31, 2022 | Lee Willis C | Director &COO | Buy | 5,000 | $0.39 | $1,925.00 | +0.9% | |
| May 23, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 7,000 | $0.49 | $3,450.00 | - | |
| May 18, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 23,351 | $0.41 | $9,572.85 | - | |
| Apr 11, 2022 | Lee Willis C | Director &COO | Buy | 15,100 | $0.89 | $13,514.00 | +1.5% |